Trial Disclosure Dispute Fuels Novo Nordisk Shareholder Lawsuit
Novo Nordisk is facing a shareholder lawsuit in the United States that has moved beyond disappointing clinical trial results to a broader question of corporate disclosure and investor transparency. According to court filings, company statements and people familiar with the case, investors allege that the Danish drugmaker failed to adequately explain key aspects of the…









